Medical Science News

RSS

Ohio State researchers develop novel anticancer peptide vaccines and inhibitors

Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

25 Sep 2014

Researchers reveal why RB1 gene mutations primarily cause retinoblastomas in children

Retinoblastoma is a childhood retinal tumor usually affecting children one to two years of age. Although rare, it is the most common malignant tumor of the eye in children.

25 Sep 2014

TSRI scientists awarded DARPA grant to build artificial immune system

Scientists from both campuses of The Scripps Research Institute have been awarded a total of $7.9 million from the Defense Advanced Research Projects Agency of the U.S. Department of Defense.

25 Sep 2014

Bacterial communication molecules can be manipulated to prevent cancer cells from spreading

Cancer, while always dangerous, truly becomes life-threatening when cancer cells begin to spread to different areas throughout the body.

25 Sep 2014

NIH, CSU scientists provide evidence that supports camels as primary carrier of MERS-CoV

National Institutes of Health and Colorado State University scientists have provided experimental evidence supporting dromedary camels as the primary reservoir, or carrier, of Middle East respiratory syndrome coronavirus (MERS-CoV).

25 Sep 2014

Northwestern scientists develop first animal model for ALS dementia

The first animal model for ALS dementia, a form of ALS that also damages the brain, has been developed by Northwestern Medicine- scientists. The advance will allow researchers to directly see the brains of living mice, under anesthesia, at the microscopic level. This will allow direct monitoring of test drugs to determine if they work.

25 Sep 2014

Novel treatment makes life-saving difference to young patients with Ph-like ALL

St. Jude Children's Research Hospital investigators found that adjusting treatment based on early response to chemotherapy made a life-saving difference to young patients with an acute lymphoblastic leukemia (ALL) subtype associated with a poor outcome.

24 Sep 2014

Research: Skin cells from pediatric patients can be used in tissue-engineered pulmonary valves

Researchers have found a way to take a pediatric patient's skin cells, reprogram the skin cells to function as heart valvular cells, and then use the cells as part of a tissue-engineered pulmonary valve.

24 Sep 2014

Preventive Medicine Reports: New open access journal from Elsevier

Elsevier, world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new peer reviewed open access journal, Preventive Medicine Reports (PMR).

24 Sep 2014

Axio Research announces launch of Statistical Genetics and Genomics services

Axio Research announced today the launch of Statistical Genetics and Genomics services in response to the biopharmaceutical industry's need for advanced statistical support in the analysis and interpretation of complex genomic data for drug discovery and development, drug repositioning, and companion diagnostics development.

24 Sep 2014

Case Western Reserve University’s synchrotron facility to become No. 1 beamline facility for biology

Case Western Reserve University’s synchrotron facility at Brookhaven National Laboratory is on its way to becoming the No. 1 beamline facility for biology in the world by early 2016, thanks to a jumpstart grant of $4.6 million from the National Institute of Biomedical Imaging and Bioengineering, a component of the National Institutes of Health.

24 Sep 2014

Sophia Genetics obtains CE-IVD mark for routine genetic tests

Sophia Genetics, the European leader in NGS data analysis, has received the CE-IVD mark for genetic testing of Familial Mediterranean Fever and Hypercholeteromia.

24 Sep 2014

ImmunoCellular signs licensing agreement with Caltech to develop antigen-specific T-cell technology

ImmunoCellular Therapeutics, Ltd. announced today that it has established a licensing agreement with the California Institute of Technology for exclusive rights to novel technology for the development of certain antigen specific T-cell immunotherapies for the treatment of cancer.

24 Sep 2014

Researchers explore gene expression in normal vestibular nerves, vestibular schwannomas

Researchers from the University of Toronto, directed by Drs. Gelareh Zadeh and Boris Krischek, investigated gene expression in normal vestibular nerves and vestibular schwannomas (VSs).

24 Sep 2014

XenOPAT aims to advance development of new drugs against cancer, personalized cancer treatments

On September 8th, the company XenOPAT SL, a spin-off of the Institute of Biomedical Research and the Catalan Institute of Oncology was established with the aim of bringing the company the latest scientific developments to the service combating cancer with two main branches: the development of new drugs and advance the implementation of personalized cancer treatments.

24 Sep 2014

New pediatric heart-defect patches enhance electrical connections between cells

Carbon nanotubes serve as bridges that allow electrical signals to pass unhindered through new pediatric heart-defect patches invented at Rice University and Texas Children's Hospital.

24 Sep 2014

Many fear lack of confidentiality and disclosure regarding genetic test's purpose

Genomic medicine is rapidly developing, bringing with its advances promises of individualized genetic information to tailor and optimize prevention and treatment interventions. Genetic tests are already guiding treatments of the human immunodeficiency virus (HIV) and hepatitis c virus (HPC), and emerging research is showing genetic variants may be used to screen for an individual's susceptibility to addiction to a substance, and even inform treatments for addiction.

24 Sep 2014

UC Riverside collaborating on NSF-funded project to study ancient lineages of fungi

The University of California, Riverside is one of 11 collaborating institutions that have been funded a total of $2.5 million by the National Science Foundation for a project focused on studying zygomycetes - ancient lineages of fungi that include plant symbionts, animal and human pathogens and decomposers of a wide variety of organic compounds.

24 Sep 2014

Mfn2 protein: A future therapeutic target for neuronal death reduction in ischemic stroke

A new study published in the prestigious publication The EMBO Journal shows that the mitochondrial protein Mfn2 may be a future therapeutic target for neuronal death reduction in the late phases of an ischemic stroke.

24 Sep 2014

Scientists identify way to find proverbial needle in cancer antigen haystack

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

24 Sep 2014

Medical Science News

Ohio State researchers develop novel anticancer peptide vaccines and inhibitors

Researchers reveal why RB1 gene mutations primarily cause retinoblastomas in children

TSRI scientists awarded DARPA grant to build artificial immune system

Bacterial communication molecules can be manipulated to prevent cancer cells from spreading

NIH, CSU scientists provide evidence that supports camels as primary carrier of MERS-CoV

Northwestern scientists develop first animal model for ALS dementia

Novel treatment makes life-saving difference to young patients with Ph-like ALL

Research: Skin cells from pediatric patients can be used in tissue-engineered pulmonary valves

Preventive Medicine Reports: New open access journal from Elsevier

Axio Research announces launch of Statistical Genetics and Genomics services

Case Western Reserve University’s synchrotron facility to become No. 1 beamline facility for biology

Sophia Genetics obtains CE-IVD mark for routine genetic tests

ImmunoCellular signs licensing agreement with Caltech to develop antigen-specific T-cell technology

Researchers explore gene expression in normal vestibular nerves, vestibular schwannomas

XenOPAT aims to advance development of new drugs against cancer, personalized cancer treatments

New pediatric heart-defect patches enhance electrical connections between cells

Many fear lack of confidentiality and disclosure regarding genetic test's purpose

UC Riverside collaborating on NSF-funded project to study ancient lineages of fungi

Mfn2 protein: A future therapeutic target for neuronal death reduction in ischemic stroke

Scientists identify way to find proverbial needle in cancer antigen haystack

This International Women’s Day, Meet the Scientist Changing Women’s Healthcare

Microphysiological systems in drug discovery

Considerations for taking ASO discovery programs into animal models

Latest News